The table below summarizes the most recent Axsome Therapeutics insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why Axsome Therapeutics insider buys are important for investors to follow.

Date	Insider	Price	Amount
11-19-2021 Insider Buy	Roger Jeffs Director	$37.30 CAGR »	$147,350.01 3,950 shares
11-18-2021 Insider Buy	Mark Coleman Director	$35.09 CAGR »	$50,180.73 1,430 shares
11-18-2021 Insider Buy	Nick Pizzie CHIEF FINANCIAL OFFICER	$35.26 CAGR »	$33,676.03 955 shares
11-17-2021 Insider Buy	Mark E. Saad Director	$34.52 CAGR »	$113,921.70 3,300 shares
5-12-2021 Insider Buy	Mark Coleman Director	$58.15 CAGR »	$29,075.00 500 shares
6-29-2020 Insider Buy	Mark Coleman Director	$78.50 CAGR »	$51,025.00 650 shares
6-26-2019 Insider Buy	Mark Coleman Director	$23.10 CAGR »	$374,280.00 16,200 shares
6-11-2019 Insider Buy	Nick Pizzie Chief Financial Officer	$20.80 CAGR »	$39,936.00 1,920 shares
5-23-2019 Insider Buy	Mark E. Saad Director	$22.33 CAGR »	$78,155.00 3,500 shares
5-13-2019 Insider Buy	Mark Coleman Director	$21.44 CAGR »	$99,696.00 4,650 shares
3-19-2019 Insider Buy	Mark Coleman Director	$12.18 CAGR »	$62,118.00 5,100 shares
3-19-2019 Insider Buy	Nick Pizzie Chief Financial Officer	$12.58 CAGR »	$67,938.60 5,400 shares
6-19-2018 Insider Buy	Nick Pizzie Chief Financial Officer	$3.10 CAGR »	$96,080.00 31,000 shares
12-23-2015 Insider Buy	Randall Kaye Chief Medical Officer	$9.03 CAGR »	$9,026.00 1,000 shares

Also See: Institutional Holders of AXSM
Also See: SEC filings

Below we present the annualized performance delivered by Axsome Therapeutics stock since 11-19-2021 (the date of the most recent insider purchase). The performance of the investment from the time Axsome Therapeutics insider buying occurred is the ultimate test of whether insiders were right about AXSM being a good buy.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	11/22/2021
End date:	05/02/2024
Start price/share:	$36.84
End price/share:	$74.19
Dividends collected/share:	$0.00
Total return:	101.38%
Average Annual Total Return:	33.21%
Starting investment:	$10,000.00
Ending investment:	$20,137.54
Years:	2.44

Axsome Therapeutics Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Axsome Therapeutics insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding AXSM

AXSM — Current Quote

Quotes delayed 20 minutes

Free AXSM Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

AXSM — Performance

Axsome Therapeutics Insider Buying

Axsome Therapeutics Insider Buying | www.HoldingsChannel.com